Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

Global deployment of an effective and safe vaccine is necessary to curtail the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we evaluated a Newcastle disease virus (NDV)-based vectored-vaccine in mice and hamsters for its immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun-Gyu, Oladunni, Fatai S., Rohaim, Mohammed A., Whittingham-Dowd, Jayde, Tollitt, James, Hodges, Matthew D.J., Fathallah, Nadin, Assas, Muhsref Bakri, Alhazmi, Wafaa, Almilaibary, Abdullah, Iqbal, Munir, Chang, Pengxiang, Escalona, Renee, Shivanna, Vinay, Torrelles, Jordi B., Worthington, John J., Jackson-Jones, Lucy H., Martinez-Sobrido, Luis, Munir, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332743/
https://www.ncbi.nlm.nih.gov/pubmed/34368648
http://dx.doi.org/10.1016/j.isci.2021.102941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332743/
https://www.ncbi.nlm.nih.gov/pubmed/34368648
http://dx.doi.org/10.1016/j.isci.2021.102941

Ejemplares similares